Work to develop vaccines and treatments for COVID-19 is continuing around the world. Companies are joining forces to boost their efforts, and progress is being made on the research front. Meanwhile, the economic impacts of the pandemic have been widespread, with big pharma companies seeing double-digit declines in their valuations over the course of the first quarter of 2020, albeit with a few exceptions.
A new alliance between GlaxoSmithKline PLC and Sanofi could prove to be a significant boost to the chances...






